Results 291 to 300 of about 2,909,744 (363)

NQO1‐Responsive Prodrug for in Cellulo Release of Cytochalasin B as Cancer Cell‐Targeted Migrastatic

open access: yesSmall, EarlyView.
The design, synthesis, biochemical, and cell biological evaluation of the NQO1‐targeted prodrug BQTML‐CB is reported. BQTML‐CB selectively releases cytochalasin B upon activation by the quinone‐oxidoreductase NQO1 associated with invasiveness of cancer cells, representing a novel approach to improve cancer selectivity and reduce immunosuppressive ...
Mervic D. Kagho   +10 more
wiley   +1 more source

Real-world procedural and clinical outcomes of contemporary balloon-expandable and self-expandable TAVR systems: a single-center experience. [PDF]

open access: yesFront Cardiovasc Med
Vinciguerra M   +6 more
europepmc   +1 more source

Xenotransplantation at a Crossroads: Breakthroughs, Challenges, and the Path Forward

open access: yes
Organ Medicine, EarlyView.
Xiaoyu Gan   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy